Cargando…
Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial
BACKGROUND: Two large randomised trials of patients with well-differentiated thyroid cancer reported in 2012 (HiLo and ESTIMABL1) found similar post-ablation success rates at 6–9 months between a low administered radioactive iodine ((131)I) dose (1·1 GBq) and the standard high dose (3·7 GBq). Howeve...
Autores principales: | Dehbi, Hakim-Moulay, Mallick, Ujjal, Wadsley, Jonathan, Newbold, Kate, Harmer, Clive, Hackshaw, Allan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Lancet, Diabetes & Endocrinology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299255/ https://www.ncbi.nlm.nih.gov/pubmed/30501974 http://dx.doi.org/10.1016/S2213-8587(18)30306-1 |
Ejemplares similares
-
Depth-resolved cellular microrheology using HiLo microscopy
por: Michaelson, Jarett, et al.
Publicado: (2012) -
Fast Calcium Imaging with Optical Sectioning via HiLo Microscopy
por: Lauterbach, Marcel A., et al.
Publicado: (2015) -
Sample size calculation in randomised phase II selection trials using a margin of practical equivalence
por: Dehbi, Hakim-Moulay, et al.
Publicado: (2020) -
Fast Optical Sectioning for Widefield Fluorescence Mesoscopy with the Mesolens based on HiLo Microscopy
por: Schniete, Jan, et al.
Publicado: (2018) -
Multi-focus microscope with HiLo algorithm for fast 3-D fluorescent imaging
por: Lin, Wei, et al.
Publicado: (2019)